Home » Newsletters » BioWorld Science

BioWorld Science

May 17, 2010

View Archived Issues

Endece's novel ER agonists block chromosome replication and show antitumor activity in vivo

Actelion claims novel calcium channel blockers

INS-115644 reduces IOP in glaucoma, ocular hypertension patients

Novel antifungal agents identified by Indian scientists

Bristol-Myers Squibb claims novel MCH-R1 antagonists

Basilea Pharmaceutica's novel tubulin polymerization inhibitors show promising preclinical activity

Novel anti-PLGF murine monoclonal antibody P-16 displays potent antitumor activity in vivo

Presidio reports preclinical data on its novel HCV NS5A inhibitor PPI-461

VAX-102 increases immune response to trivalent influenza vaccine

Promising phase II data on JX-594 in HCC support phase III evaluation

Chimerix initiates first-in-human phase I study of CMX-157

Array BioPharma discloses novel Trk kinase inhibitors

DMC recommends continuation of phase III ThermoDox HEAT study

Merck & Co. identifies novel orexin receptor antagonists

Repligen files IND with FDA for Friedreich's ataxia drug

Meda acquires European rights from Graceway to new imiquimod formulation for AK

Rexahn to move forward with phase IIb trial of Zoraxel for ED

Octapharma launches Wilate for von Willebrand disease

FDA assigns November 4, 2010 action date for Cadence's Ofirmev NDA

Roche to begin study of TB-403 in patients with colorectal and ovarian cancer

Amgen submits BLA for denosumab for skeletal-related events in cancer patients

SRI International's SR-16388 has promise for multiple myeloma

Astellas to acquire OSI Pharmaceuticals

FDA recommends resumption of use of Rotarix

Lundbeck announces results of pivotal Japanese study of escitalopram

SciClone provides update on clinical program for SCV-07 in oral mucositis

Popular Stories

NIH changes set industry up for workforce, ideas drought
BioWorld
On March 1, 2025, former NIH director Francis Collins’ announced that he had fully resigned from the NIH, where he continued to lead a laboratory after his...
Today's news in brief
BioWorld
BioWorld briefs for March 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for March 12, 2025
At CROI, HIV cure trials raise hopes for broader applicability
BioWorld
At the 2025 meeting of the Conference on Retroviruses and Opportunistic Infections (CROI) it was the best of times, it was the worst of times. On the first full...
Hummingbird migrates ADCs, tech to newco Callio’s $187M debut
BioWorld
Antibody-drug conjugate (ADC)-focused Callio Therapeutics debuted on March 3 with the closing of a $187 million series A financing round based on cancer drug...